Cipla Q2 FY27 results: Pharmaceutical major Cipla reported a 35 percent year-on-year decline in consolidated net profit to Rs 877.54 crore for the fiscal second quarter, compared with Rs 1,351 crore in the corresponding quarter last year. The decline came amid weaker sales in North America and a sharp contraction in operating profitability. Revenue from operations fell 2.4 percent year-on-year to Rs 7,403.93 crore, compared with Rs 7,589 crore in the year-ago period.
Earnings before interest, tax, depreciation and amortisation (EBITDA) declined 26.8 percent to Rs 1,388 crore from Rs 1,895 crore a year earlier. EBITDA margin contracted sharply to 18.7 percent from 25 percent, a decline of 630 basis points.
Cipla shares were trading 0.6 percent lower at Rs 1,347 apiece in afternoon trade on Tuesday, following the announcement of the company's quarterly earnings.
Share Markets Live Updates | Sensex, Nifty, GIFT Nifty Today
Cipla's India business emerged as a key growth driver during the September quarter, with revenue rising 12 percent year-on-year to Rs 3,516 crore from Rs 3,146 crore. The company said its One-India business recorded its highest-ever quarterly sales. However, North America revenue declined 19 percent to Rs 1,643 crore from Rs 2,039 crore a year earlier. The business generated quarterly revenue of $172 million.